Mural Oncology plc (MURA) — Working Capital to Net Assets Ratio
Mural Oncology plc (MURA) has a Working Capital to Net Assets ratio of 93.6% as of September 2025. Working capital of $51.63 Million (current assets of $62.16 Million minus current liabilities of $10.53 Million) is measured against net assets of $55.19 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See MURA equity to assets ratio to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Mural Oncology plc Working Capital to Net Assets (2021–2024)
This chart shows how Mural Oncology plc's Working Capital to Net Assets ratio has evolved across 4 annual periods from 2021 to 2024. As of September 2025, the ratio stands at 93.6%, reflecting working capital of $51.63 Million against net assets of $55.19 Million USD. Check Mural Oncology plc tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Mural Oncology plc (2021–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Mural Oncology plc from 2021 to 2024, covering 4 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see MURA market cap overview.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 90.2% | $126.72 Million | $140.50 Million | $152.92 Million | $26.20 Million | ▼ -3.9 pp |
| 2023 | 94.1% | $248.32 Million | $263.82 Million | $277.34 Million | $29.02 Million | ▼ -75.5 pp |
| 2022 | 169.7% | $-36.74 Million | $-21.66 Million | $4.82 Million | $41.56 Million | ▲ +7.4 pp |
| 2021 | 162.2% | $-29.01 Million | $-17.88 Million | $4.24 Million | $33.25 Million | — |